Diagnostic challenges of recurrent malaria in non-endemic areas-Reference-Cited by-同舟云学术

Diagnostic challenges of recurrent malaria in non-endemic areas

Published:2024-03-08 Issue:3 Volume:31 Page:
ISSN:1195-1982
Container-title:Journal of Travel Medicine
language:en
Short-container-title:

Author:

Ramirez-Hidalgo Maria F¹²^ORCID,González Eric López³,Moles Silvia Iglesias⁴,García Cristina Acosta⁵,Muñoz Jose Miguel Rubio⁶^ORCID,Ortega Ricard López⁷,Navés Laura Gros⁸,Sánchez Albert Bernet³,Jover-Sáenz Alfredo²

Affiliation:

1. Unidad de Medicina Tropical, Hospital Universitari Arnau de Vilanova , 25198, Lleida

2. Unidad de Infecciones Nosocomiales, Hospital Universitari Arnau de Vilanova , 25198, Lleida

3. Sección de Microbiología, Hospital Universitari Arnau de Vilanova , 25198, Lleida

4. Servicio de Medicina Intensiva, Hospital Universitari Arnau de Vilanova , 25198, Lleida

5. Servicio de Medicina Interna, Hospital Universitari Arnau de Vilanova , 25198, Lleida

6. Laboratorio de Malaria y Protozoos Emergentes, Centro Nacional de Microbiología Instituto de Salud Carlos III , 28220, Madrid

7. Unitat de Citogenètica i Genètica Mèdica, Hospital Universitari Arnau de Vilanova , 25198, Lleida

8. ABS Lleida Rural Nord, Gestió de Serveis Sanitaris , 25110, Lleida

Abstract

In Spain, a patient’s unexpected relapse with Plasmodium falciparum raises questions about genetic influences on treatment efficacy. Meanwhile, in a separate case, a recurrence of Plasmodium malariae prompts speculation on latent reservoirs and treatment strategies. Here, we delve into these complex cases that underscore the evolving landscape of malaria.

Publisher

Oxford University Press (OUP)

Link

https://academic.oup.com/jtm/advance-article-pdf/doi/10.1093/jtm/taae041/57063541/taae041.pdf

Reference5 articles.

1. Variation in CYP2A6 activity and personalized medicine;Tanner;J Pers Med,2017

2. Preliminary investigation of the contribution of CYP2A6, CYP2B6, and UGT1A9 polymorphisms on artesunate-mefloquine treatment response in Burmese patients with Plasmodium falciparum malaria;Phompradit;Am J Trop Med Hyg,2014

3. Plasmodium malariae after successful treatment of P. falciparum malaria with artemether-lumefantrine;Tournoy;Int J Infect Dis,2022

4. A case of Plasmodium malariae recurrence: Recrudescence or reinfection?;Grande;Malar J,2019

5. Recurrence of Plasmodium malariae and P. falciparum following treatment of uncomplicated malaria in north Sumatera with dihydroartemisinin-piperaquine or artemether-lumefantrine;Lubis;Open Forum Infect Dis,2020